Measuring brain activity on the go

Brain activity has traditionally been assessed using large and often expensive technology that has limited its use to specific clinical settings. Small wearable devices that can assess brain activity show promise for improving the diagnosis and monitoring of brain diseases like dementia or depression. In a study published recently in Advanced Materials Technologies, researchers from […]

Continue Reading

Brain discovery holds key to boosting body’s ability to fight Alzheimer’s, multiple sclerosis

UVA Health researchers have discovered a molecule in the brain responsible for orchestrating the immune system’s responses to Alzheimer’s disease and multiple sclerosis (MS), potentially allowing doctors to supercharge the body’s ability to fight those and other devastating neurological diseases. The molecule the researchers identified, called a kinase, is crucial to both removing plaque buildup […]

Continue Reading

Researchers detect monkeypox virus in testes of nonhuman primate survivors

For the first time, scientists have detected monkeypox virus in the testes of macaques during the acute phase of infection, according to research published online today in the journal Nature Microbiology. In addition, the team found preliminary evidence of persistent infection in two animals that survived challenge with the virus. Their results highlight the potential […]

Continue Reading

Air pollution from factories and vehicles linked to worse outcomes for patients with lung disease

People with a disease characterized by lung scarring that has no obvious cause are more likely to die if they live in areas with higher levels of air pollution composed of chemicals associated with industrial sources and vehicular traffic, according to new research led by University of Pittsburgh scientists. The study, published today in JAMA […]

Continue Reading

A new drug target for triple-negative breast cancer

Research led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans’ Schools of Medicine and Graduate Studies, reports a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy drug suppresses the growth of triple-negative breast cancer cells synergistically. The findings are published in Oncogene. After screening the National Cancer Institute’s […]

Continue Reading